N/A N=12 Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
Stage IV Prostate Cancer
Primary: Number of Participants With PSA < 0.6 ng/mL — 5 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=3,085 Decision Aids for the Management of Suspicious Occlusal Caries Lesions
Dental Caries
Primary: Number of Lesions That Received Invasive Treatment and the Number of Lesions Receiving Invasive Treatment That Extended Into Dentin — 603; 246; 213; 248 lesions
Phase 1 N=70 A Study of LY2484595 on Pharmacokinetics in Healthy Participants
Healthy Participants
Primary: Part 1: Number of Participants With 1 or More Adverse Events (AEs) or Any Serious AEs — 7; 2; 4; 2 Participants
Phase 3 N=1,315 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
Bacterial Infections · Virus Diseases
Primary: Acceptability of Antibody (Ab) Response or Seroresponse Rates to All Antigens Contained in PR5I Vaccine One Month After the Toddler Dose of PR5I (11 to 12 Months of Age)…
N/A N=24 Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)
Eosinophilic Esophagitis
Primary: Percentage of Histologic Responders — 21 percentage of participants
Phase 3 N=12 Hydrocortisone for Term Hypotension
Infant, Newborn, Diseases · Cardiovascular Insufficiency
Primary: Death — 6; 6; 0; 0 Participants
Phase 2 N=75 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer
Colorectal Cancer
Primary: Percent of Patients With Disease Control — 18 Participants
N/A N=47 Kinetic Anesthesia Device Study
Local Anaesthetic Complication · Pain
Primary: Pain of Lidocaine Injection, Measured by Visual Analog Scale. — 7.5; 26 mm on visual analog scale
Phase 1 N=49 A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia
Hairy Cell Leukemia
Primary: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
Phase 2 N=341 Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Neuroendocrine Tumors · Von Hippel-Lindau Syndrome · Hippel-Lindau Disease
Primary: Number of Lesions Detected Using the 68Gallium-DOTATATE Positron Emission Tomography (PET/Computed Tomography (CT)) Scan — 847 Number of lesions
Phase 2 N=124 An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Colitis, Ulcerative
Primary: Number of Subjects Who Achieve Clinical Remission at Week 8 Using Modified Mayo Score. — 7; 12 Participants — p=0.106
Phase 4 N=68 Comparison of Bacteriostatic Saline to Buffered Lidocaine for Ultrasound Guided Hip Joint Injection Local Anesthesia
Hip Pain
Primary: VAS for Pain Score During Local Anesthesia Infiltration — 13.2; 14 score on a scale — p=0.82
Phase 3 N=631 Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause
Vaginal Dryness
Primary: Change From Baseline in the Percentage of Parabasal Cells in the Maturation Index of the Vaginal Smear at Week 12 — -23.7; -1.9 percentage of cells — p=<0.0001
N/A N=19 Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
HIV
Primary: AUC — 94.17; 34.67; 100.44; 32.58 h*microgram/mL
N/A N=32 Semi-Recumbent Vibration Therapy in Older Adults
Sarcopenia · Aging
Primary: Weight Corrected Jump Power Based on Participant's Jump on the Jump Force Plate — 10.53; 10.28; 11.10; 8.98 W/kg — p=0.217